Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Improved drug efficacy assessment using joint Bayesian estimation framework

Award Number: R01EB035093
ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/17/2024
PERIOD OF PERFORMANCE END DATE: 02/29/2028

Group Awards By:

View Award Description

Improved drug efficacy assessment using joint Bayesian estimation framework - Abstract The development of central nervous system (CNS) drugs requires imaging tools that can quantify drug efficacy and target engagement as well as the effects of drug concentration on these quantitative assessment measures. Positron emission tomography (PET) imaging has become standard practice for quantitative assessment, thanks to its ability to image tracers that bind to target receptors of drugs. Receptor occupancy (RO) studies, which consist in a pair of PET scans, baseline and post-drug injection, can be used to quantify, as a function of drug concentration, the blocking effect of a drug. The concentration yielding half-maximum blocking effect, called EC50, is determined by first estimating receptor occupancy for each pair of scans, then fitting a logistic model to the occupancy vs. concentration curve. The conventional method to estimate RO and EC50 consists in reconstructing the dynamic PET data for each pair of scans, perform kinetic fitting, typically in high binding regions, to estimate the binding potential and calculate RO, before performing the logistic fit across concentrations to obtain EC50. The resulting estimates have low precision due to the noise in dynamic PET images and the lack of proper noise modeling. Moreover, estimating single RO and EC50 values discards potentially valuable information on the spatial distribution of RO and EC50. We propose an estimation framework that jointly estimates spatial RO maps for each pair of scans and a global EC50 map using an end-to-end model from the PET measurements to the estimated EC50. The estimation framework relies on advanced optimization strategies to decompose the joint estimation process into manageable subproblems, such as image reconstruction, parametric fitting, image denoising and logistic fitting. The method is expected to improve the estimation of RO and EC50 over conventional methods, while offering additional spatial information. The targeted improvement in estimation would allow to reduce the sample size required in drug trials to achieve the same statistical power as conventional approaches (or conversely, increase the statistical power for a fixed sample size). The method will be validated in numerical simulations and applied to in vivo animal studies.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $420,228 )
2026	2026	YALE UNIV	150 MUNSON ST	NEW HAVEN	CT	06511	SOUTH CENTRAL CT	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	3	2/19/2026	NON-COMPETING CONTINUATION	$420,228
														Subtotal = $420,228

Issue Date FY: 2025 ( Subtotal = $430,922 )
2025	2025	YALE UNIV	150 MUNSON ST	NEW HAVEN	CT	06511	SOUTH CENTRAL CT	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	2	3/21/2025	NON-COMPETING CONTINUATION	$387,830
2025	2025	YALE UNIV	150 MUNSON ST	NEW HAVEN	CT	06511	SOUTH CENTRAL CT	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	2	6/25/2025	NON-COMPETING CONTINUATION	$43,092
														Subtotal = $430,922

Issue Date FY: 2024 ( Subtotal = $348,595 )
2024	2024	YALE UNIV	150 MUNSON ST	NEW HAVEN	CT	06511	SOUTH CENTRAL CT	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	1	5/15/2024	NEW	$348,595
														Subtotal = $348,595

Grand Total All Awards = $1,199,745

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Improved drug efficacy assessment using joint Bayesian estimation framework

Award Number: R01EB035093

ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/17/2024

PERIOD OF PERFORMANCE END DATE: 02/29/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer